rs45608240

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015192.4(PLCB1):​c.1469A>G​(p.Tyr490Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00585 in 1,613,838 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y490Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 24 hom. )

Consequence

PLCB1
NM_015192.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 1.25

Publications

11 publications found
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PLCB1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 12
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005054921).
BP6
Variant 20-8717804-A-G is Benign according to our data. Variant chr20-8717804-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 129902.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00376 (572/152298) while in subpopulation NFE AF = 0.00644 (438/68030). AF 95% confidence interval is 0.00594. There are 1 homozygotes in GnomAd4. There are 228 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.1469A>G p.Tyr490Cys missense_variant Exon 14 of 32 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.1469A>G p.Tyr490Cys missense_variant Exon 14 of 33 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.1469A>G p.Tyr490Cys missense_variant Exon 14 of 32 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
573
AN:
152180
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00644
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00354
AC:
887
AN:
250292
AF XY:
0.00351
show subpopulations
Gnomad AFR exome
AF:
0.000989
Gnomad AMR exome
AF:
0.00250
Gnomad ASJ exome
AF:
0.00319
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00144
Gnomad NFE exome
AF:
0.00580
Gnomad OTH exome
AF:
0.00476
GnomAD4 exome
AF:
0.00607
AC:
8871
AN:
1461540
Hom.:
24
Cov.:
31
AF XY:
0.00588
AC XY:
4276
AN XY:
727056
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33456
American (AMR)
AF:
0.00282
AC:
126
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.00291
AC:
76
AN:
26126
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39686
South Asian (SAS)
AF:
0.00126
AC:
109
AN:
86222
European-Finnish (FIN)
AF:
0.00163
AC:
87
AN:
53370
Middle Eastern (MID)
AF:
0.000868
AC:
5
AN:
5762
European-Non Finnish (NFE)
AF:
0.00728
AC:
8099
AN:
1111864
Other (OTH)
AF:
0.00573
AC:
346
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
424
849
1273
1698
2122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00376
AC:
572
AN:
152298
Hom.:
1
Cov.:
32
AF XY:
0.00306
AC XY:
228
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00132
AC:
55
AN:
41566
American (AMR)
AF:
0.00196
AC:
30
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4826
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00644
AC:
438
AN:
68030
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00500
Hom.:
5
Bravo
AF:
0.00401
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00908
AC:
35
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00651
AC:
56
ExAC
AF:
0.00353
AC:
429
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00622
EpiControl
AF:
0.00558

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 12 Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 14, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 12, 2015
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 27, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Dec 21, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32970752) -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLCB1: BP4, BS2 -

Early Infantile Epileptic Encephalopathy, Autosomal Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 17, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

PLCB1-related disorder Benign:1
Nov 22, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
13
DANN
Benign
0.69
DEOGEN2
Uncertain
0.50
.;.;.;T;.;T;.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.84
T;T;.;T;T;T;T;T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.0051
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.49
.;.;N;N;N;.;.;.
PhyloP100
1.2
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.5
.;.;N;N;N;.;.;.
REVEL
Benign
0.15
Sift
Benign
0.18
.;.;T;T;T;.;.;.
Sift4G
Benign
0.18
.;T;T;T;T;T;T;T
Polyphen
0.0010, 0.0
.;.;B;B;B;.;.;.
Vest4
0.13, 0.14, 0.13
MVP
0.32
MPC
1.3
ClinPred
0.0058
T
GERP RS
-1.8
Varity_R
0.061
gMVP
0.24
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45608240; hg19: chr20-8698451; COSMIC: COSV99059812; API